Fluspirilene

Known as: Fluspirilenum, Spirodiflamine, Fluspirilene [Chemical/Ingredient] 
A long-acting injectable antipsychotic agent used for chronic schizophrenia.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Surgical resection and… (More)
Is this relevant?
Review
2001
Review
2001
Up to 5% of all hospital admissions are the result of adverse drug reactions (ADRs). Identifying those factors which may… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Risperidone and its active metabolite 9-OH-risperidone were compared to reference antipsychotic drugs (haloperidol, pipamperone… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Four different types of Ca2+ channel alpha 1 subunits, representing the major classes of voltage-gated Ca2+ channels, were… (More)
Is this relevant?
1994
1994
1. High voltage-activated calcium currents were recorded in nerve growth factor (NGF)-differentiated PC12 cells with the whole… (More)
Is this relevant?
1986
1986
A 4-week double-blind controlled clinical trial was carried out in which fluspirilene, an injectable diphenylbutylpiperidine… (More)
Is this relevant?
1980
1980
The paper reports on an open study of flupirilene administration in ten previously untreated female outpatients with paranoid… (More)
Is this relevant?
1978
1978
Fifty chronic schizophrenics were randomly assigned to a 16-week treatment either with fluspirilene or with fluphenazine… (More)
Is this relevant?
1977
1977
  • Som Soni
  • Current medical research and opinion
  • 1977
A study was carried out to assess the efficacy of fluspirilene, a long-acting psychotropic agent, in the treatment of 29 non… (More)
Is this relevant?
1976
1976
Fluspirilene proved to be a very useful drug in the basic maintenance therapy of 21 chronic schizophrenic patients (ages 16-71… (More)
Is this relevant?